TSPC.JK(TSPC.JK)
TSPC.JK
PT Tempo Scan Pacific Tbk is a leading Indonesian pharmaceutical company specializing in both specialty and generic drugs, with a strong presence in the Southeast Asian market. The company differentiates itself through its extensive distribution network and a diverse product portfolio, including prescription medications and over-the-counter products.
Tempo Scan generates revenue primarily through the sale of prescription and over-the-counter medications, leveraging its established relationships with healthcare providers and pharmacies. The company benefits from strong brand recognition and a robust distribution network, which enhances its pricing power and market penetration.
Regulatory approvals for new drugs
Changes in healthcare policies affecting drug pricing
Market share shifts in the Indonesian pharmaceutical sector
Fluctuations in raw material costs impacting margins
Regulatory changes impacting drug approval processes
Technological disruption in drug manufacturing and delivery
Increased competition from generic drug manufacturers
Potential market entry of multinational pharmaceutical companies
Low liquidity risk due to a current ratio of 3.33
Potential risks associated with currency fluctuations impacting imported raw materials
moderate - The pharmaceutical sector is somewhat insulated from economic downturns, but consumer spending on non-essential healthcare products can be affected by GDP fluctuations.
Interest rates have a limited direct impact on Tempo Scan’s operations; however, higher rates could increase financing costs for expansion projects and affect overall market valuations.
minimal - The company has a low debt-to-equity ratio of 0.12, indicating limited reliance on external financing.
value - The company’s low valuation multiples (P/S of 0.8x) may attract value investors looking for undervalued stocks in the healthcare sector.
low - The stock has shown relatively stable performance with a beta lower than 1, indicating lower volatility compared to the broader market.